| 000 | 03541cam a22004578i 4500 | ||
|---|---|---|---|
| 001 | 22046807 | ||
| 003 | CSPC | ||
| 005 | 20250429151448.0 | ||
| 008 | 210524s2021 enk b 001 0 eng | ||
| 010 | _a 2021024710 | ||
| 020 |
_a9781108971638 _q(paperback) |
||
| 040 |
_aDLC _beng _erda _cDLC _dCSPC |
||
| 042 | _apcc | ||
| 050 | 0 | 0 |
_aRC483 _b.S67 2021 |
| 082 | 0 | 0 |
_a616.8918 _bSt141s _223 |
| 084 |
_aMED102000 _aMED102000 _2bisacsh |
||
| 100 | 1 |
_aStahl, Stephen M., _d1951- _eauthor. |
|
| 245 | 1 | 0 |
_aStahl's essential psychopharmacology : _bneuroscientific basis and practical applications / _cStephen M. Stahl. |
| 246 | 3 | 0 | _aEssential psychopharmacology |
| 250 | _aFifth edition. | ||
| 263 | _a2108 | ||
| 264 | 1 |
_aCambridge, United Kingdom ; _aNew York : _bCambridge University Press, _c2021. |
|
| 300 |
_axiv, 623 pages : _bcolor illustrations ; _c25 cm. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_aunmediated _bn _2rdamedia |
||
| 338 |
_avolume _bnc _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aChemical neurotransmission -- Transporters, receptors and enzymes as targets of psychopharmacological drug action -- Ion channels as targets of psychopharmacological drug action -- Psychosis, schizophrenia, and the neurotransmitters networks dopamine, serotonin, and glutamate-- Targeting dopamine and serotonin receptors for psychosis, mood, and beyond: so- called "Antipsychotics" -- Mood disorders and the neurotransmitter network norepinephrine and aminobutyric acid (GABA) -- Treatments for mood disorders: so-called "antidepressants" and "mood stabilizers" -- Anxiety, trauma and treatment-- Chronic pain and its treatment -- Disorders of sleep and wakefulness and their treatment: neurotransmitter networks for histamine and orexin-- Attention deficit hyperactivity disorder and its treatment -- Dementia: causes, symptomatic treatments, and the neurotransmitter network acetylcholine -- Impulsivity, compulsivity and addiction. | |
| 520 |
_a"For this 5th edition of Stahl's Essential Psychopharmacology you will notice that every figure in the book has been revised, refreshed and updated with new colors, shading and outlining. About half the figures are entirely new. The number of chapters has decreased by one, with merger of mood stabilizers into treatments for mood disorders; the text itself and the total number of figures and tables are all approximately the same in length and number, although all chapters have been edited, most of them extensively with the details of what has changed listed below. The number of references has now been doubled. Overall, 14 drugs have new uses and indications presented, and 18 brand new drugs are introduced and discussed"-- _cProvided by publisher. |
||
| 650 | 0 |
_aMental illness _xChemotherapy. |
|
| 650 | 0 | _aPsychopharmacology. | |
| 650 | 7 |
_aMEDICAL / Mental Health _2bisacsh |
|
| 650 | 7 |
_aMEDICAL / Mental Health _2bisacsh |
|
| 700 | 1 |
_aGrady, Meghan M., _eeditor. |
|
| 700 | 1 |
_aMuntner, Nancy, _eillustrator. |
|
| 776 | 0 | 8 |
_iOnline version: _aStahl, Stephen M., 1951- _tStahl's essential psychopharmacology _bFifth edition. _dCambridge, United Kingdom ; New York, NY : Cambridge University Press, 2021 _z9781108975292 _w(DLC) 2021024711 |
| 906 |
_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg |
||
| 942 |
_2ddc _cBK _e23 _h616.8918 _iSt141s _kNUR _m2021 _n0 |
||
| 999 |
_c29442 _d29442 |
||